Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients

NCT04416841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2022-09-22

No results posted yet for this study

Summary

The patients with type 2 diabetes mellitus (T2DM) is expected to rise to 439 million in 2030, accounting for 7.7% the population in the world. There are nearly 10 million T2DM patients with mild cognitive impairment (MCI) among people over 65 years old , accounting for about 8% of the people over 65 years old in China. The medical cost for patients with T2DM/MCI is 2.5 to 4 times higher than those without T2DM. And T2DM will increase the risk of cognitive impairment, and lead to various complications which will bring serious social and medical economic burden.

Conditions

  • Diabetes Mellitus, Type 2
  • Cognitive Dysfunction

Interventions

BEHAVIORAL

Tai Chi Chuan

Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.

BEHAVIORAL

Fitness Walking

Participants would take fitness walking training 1 hour/session, 3sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes fitness walking and 10 minutes cool-down exercises in the fitness walking training, the exercise intensity was 50% to 70% of the maximum heart rate. Besides, they would also take standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.

BEHAVIORAL

Standard Diabetic Care Education

Participants would take standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.

Sponsors & Collaborators

  • Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

    collaborator OTHER
  • Bao'an District People's Hospital of Shenzhen

    collaborator UNKNOWN
  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER
  • Peking University

    collaborator OTHER
  • University of Electronic Science and Technology of China

    collaborator OTHER
  • Jing Tao

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-03
Primary Completion
2022-03-15
Completion
2022-08-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04416841 on ClinicalTrials.gov